4.4 Article

Symptom-based case definitions for COVID-19: Time and geographical variations for detection at hospital admission among 260,000 patients

期刊

INFLUENZA AND OTHER RESPIRATORY VIRUSES
卷 16, 期 6, 页码 1040-1050

出版社

WILEY
DOI: 10.1111/irv.13039

关键词

case definitions; COVID-19; hospitalisation

资金

  1. UK Foreign, Commonwealth and Development Office
  2. Wellcome Trust [215091/Z/18/Z, 205228/Z/16/Z, 220757/Z/20/Z]
  3. Bill and Melinda Gates Foundation [OPP1209135]
  4. University of Oxford's COVID-19 Research Response Fund [0009109]
  5. CIHR Coronavirus Rapid Research Funding Opportunity [OV2170359]
  6. Sunnybrook Research Institute
  7. endorsement of the Irish Critical Care-Clinical Trials Group
  8. Irish Critical Care-Clinical Trials Network at University College Dublin
  9. Health Research Board of Ireland [CTN-2014-12]
  10. Rapid European COVID-19 Emergency Response research (RECOVER) [101003589]
  11. European Clinical Research Alliance on Infectious Diseases (ECRAID) [965313]
  12. COVID Clinical Management Team, AIIMS, Rishikesh, India
  13. COVID-19 Clinical Management Team, Manipal Hospital Whitefield, Bengaluru, India
  14. Cambridge NIHR Biomedical Research Centre
  15. Groote Schuur Hospital Covid ICU Team
  16. Liverpool School of Tropical Medicine
  17. University of Oxford
  18. Norwegian SARS-CoV-2 Study Team
  19. Research Council of Norway [312780]
  20. Vivaldi Invest A/S owned by Jon Stephenson von Tetzchner
  21. Imperial NIHR Biomedical Research Centre
  22. Comprehensive Local Research Networks (CLRNs) of which PJMO is an NIHR Senior Investigator [NIHR201385]
  23. Innovative Medicines Initiative Joint Undertaking [115523]
  24. European Union [FP7/2007-2013]
  25. EFPIA companies, in-kind contribution
  26. INSERM [NCT04262921]
  27. REACTing (REsearch & ACtion emergING infectious diseases) Consortium
  28. French Ministry of Health [20-0424]
  29. Stiftungsfonds zur Forderung der Bekampfung der Tuberkulose und anderer Lungenkrankheiten of the City of Vienna [APCOV22BGM]
  30. Italian Ministry of Health `Fondi Ricerca corrente-L1P6' [3273191]
  31. Gender Equity Strategic Fund at University of Queensland, Artificial Intelligence for Pandemics (A14PAN) at University of Queensland
  32. Australian Research Council Centre of Excellence for Engineered Quantum Systems (EQUS) [CE170100009]
  33. Prince Charles Hospital Foundation, Australia
  34. Instituto de Salud Carlos III, Ministerio de Ciencia, Spain
  35. Brazil, National Council for Scientific and Technological Development Scholarship [303953/2018-7]
  36. Firland Foundation, Shoreline, Washington, USA
  37. foundation Bevordering Onderzoek Franciscus
  38. South Eastern Norway Health Authority
  39. Research Council of Norway
  40. Ministry of Health Malaysia
  41. National Institute for Health Research (NIHR) [CO-CIN-01]
  42. Medical Research Council (MRC) [MC_PC_19059]
  43. NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE) [200907]
  44. NIHR HPRU in Respiratory Infections at Imperial College London with PHE [200927]
  45. Liverpool Experimental Cancer Medicine Centre [C18616/A25153]
  46. NIHR Biomedical Research Centre at Imperial College London [ISBRC-1215-20013]
  47. Wellcome Trust [220757/Z/20/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

This study analyzed the proportion of laboratory-confirmed COVID-19 hospitalized patients meeting different case definitions in the ISARIC prospective cohort study database. The study found that the performance of case definitions may vary by region, age, and time. Older patients often did not meet case definitions, which could lead to delayed medical care.
Introduction: Case definitions are used to guide clinical practice, surveillance and research protocols. However, how they identify COVID-19-hospitalised patients is not fully understood. We analysed the proportion of hospitalised patients with laboratory-confirmed COVID-19, in the ISARIC prospective cohort study database, meeting widely used case definitions. Methods: Patients were assessed using the Centers for Disease Control (CDC), European Centre for Disease Prevention and Control (ECDC), World Health Organization (WHO) and UK Health Security Agency (UKHSA) case definitions by age, region and time. Case fatality ratios (CFRs) and symptoms of those who did and who did not meet the case definitions were evaluated. Patients with incomplete data and non-laboratory-confirmed test result were excluded. Results: A total of 263,218 of the patients (42%) in the ISARIC database were included. Most patients (90.4%) were from Europe arid Central Asia. The proportions of patients meeting the case definitions were 56.8% (WHO), 74.4% (UKHSA), 81.6% (ECDC) and 82.3% (CDC). For each case definition, patients at the extremes of age distribution met the criteria less frequently than those aged 30 to 70 years; geographical and time variations were also observed. Estimated CFRs were similar for the patients who met the case definitions. However, when more patients did riot meet the case definition, the CFR increased. Conclusions: The performance of case definitions might be different in different regions and may change over time. Similarly concerning is the fact that older patients often did not meet case definitions, risking delayed medical care. While epidemiologists must balance their analytics with field applicability, ongoing revision of case definitions is necessary to improve patient care through early diagnosis and limit potential nosocomial spread.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据